{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:54:20Z","timestamp":1790387660899,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.jim.2005.12.003","type":"journal-article","created":{"date-parts":[[2006,1,28]],"date-time":"2006-01-28T12:10:36Z","timestamp":1138450236000},"page":"182-191","source":"Crossref","is-referenced-by-count":16,"title":["A pattern of anti-carbohydrate antibody responses present in patients with advanced atherosclerosis"],"prefix":"10.1016","volume":"309","author":[{"given":"David E.","family":"Mosedale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Grainger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2005.12.003_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8","article-title":"Genetic events and the role of TGF beta in epithelial tumour progression","volume":"187","author":"Akhurst","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.jim.2005.12.003_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.CIR.100.6.614","article-title":"Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes","volume":"100","author":"Aukrust","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jim.2005.12.003_bib3","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0021-9258(19)44247-6","article-title":"Enzymatic synthesis of a blood group B-related pentaglycosylceramide by an alpha-galactosyltransferase from rabbit bone marrow","volume":"248","author":"Basu","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2005.12.003_bib4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3891\/acta.chem.scand.25-0750","article-title":"Structural studies on Klebsiella O groups 1 and 6 lipopolysaccharides","volume":"25","author":"Bjorndal","year":"1971","journal-title":"Acta Chem. Scand."},{"key":"10.1016\/j.jim.2005.12.003_bib5","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.4049\/jimmunol.160.5.2145","article-title":"CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+B cell line","volume":"160","author":"Cerutti","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2005.12.003_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4049\/jimmunol.119.5.1727","article-title":"Measurement of IgD by a double antibody radioimmunoassay: demonstration of an apparent trimodal distribution of IgD levels in normal human sera","volume":"119","author":"Dunnette","year":"1977","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2005.12.003_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/acta.0.1150067","article-title":"Elevated anti-alpha-galactosyl antibody titres. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmopathy?","volume":"115","author":"Etienne-Decerf","year":"1987","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"10.1016\/j.jim.2005.12.003_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-4615-4771-6_14","article-title":"Graves' disease as a model for anti-Gal involvement in autoimmune diseases","volume":"32","author":"Galili","year":"1999","journal-title":"Sub-cell. Biochem."},{"key":"10.1016\/j.jim.2005.12.003_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.160.5.1519","article-title":"A unique natural human IgG antibody with anti-alpha-galactosyl specificity","volume":"160","author":"Galili","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2005.12.003_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.165.3.693","article-title":"The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies","volume":"165","author":"Galili","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2005.12.003_bib11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1073\/pnas.84.5.1369","article-title":"Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1\u20133Gal epitope in primates","volume":"84","author":"Galili","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2005.12.003_bib12","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/IAI.56.7.1730-1737.1988","article-title":"Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora","volume":"56","author":"Galili","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2005.12.003_bib13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00007890-199804270-00020","article-title":"A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody","volume":"65","author":"Galili","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jim.2005.12.003_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1469-185X.1995.tb01652.x","article-title":"A pivotal role for TGF-beta in atherogenesis?","volume":"70","author":"Grainger","year":"1995","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.jim.2005.12.003_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm0195-74","article-title":"The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis","volume":"1","author":"Grainger","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2005.12.003_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s001980050163","article-title":"The role of serum TGF-beta isoforms as potential markers of osteoporosis","volume":"9","author":"Grainger","year":"1999","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jim.2005.12.003_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1359-6101(99)00037-4","article-title":"TGF-beta in blood: a complex problem","volume":"11","author":"Grainger","year":"2000","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jim.2005.12.003_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/CDLI.2.2.125-131.1995","article-title":"Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions","volume":"2","author":"Hamadeh","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2005.12.003_bib19","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/art.1780331206","article-title":"Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis","volume":"33","author":"Hammer","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2005.12.003_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0009-8981(95)06201-7","article-title":"Plasma levels of transforming growth factor beta 1 in chronic liver disease","volume":"244","author":"Hayasaka","year":"1996","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jim.2005.12.003_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1432-1033.1981.tb06241.x","article-title":"Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae","volume":"115","author":"Jansson","year":"1981","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jim.2005.12.003_bib22","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.158.13.1434","article-title":"Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M","volume":"158","author":"Kovanen","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jim.2005.12.003_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/glycob\/cwf087","article-title":"A complete alpha1,3-galactosyltransferase gene is present in the human genome and partially transcribed","volume":"12","author":"Lanteri","year":"2002","journal-title":"Glycobiology"},{"key":"10.1016\/j.jim.2005.12.003_bib24","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/intimm\/11.11.1819","article-title":"T(h)2 cytokine dependence of IgD production by normal human B cells","volume":"11","author":"Levan-Petit","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jim.2005.12.003_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1566523044578004","article-title":"TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy","volume":"4","author":"Liu","year":"2004","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jim.2005.12.003_bib26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/15271","article-title":"Requirement for CD154 in the progression of atherosclerosis","volume":"5","author":"Lutgens","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2005.12.003_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jim.2005.12.003_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00041433-200210000-00008","article-title":"The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives","volume":"13","author":"Mallat","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"issue":"Pt 1","key":"10.1016\/j.jim.2005.12.003_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/0264-6021:3430125","article-title":"An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system","volume":"343","author":"Mosedale","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.jim.2005.12.003_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/bj3430125","article-title":"An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system","volume":"343","author":"Mosedale","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.jim.2005.12.003_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0021-9150(88)90204-3","article-title":"Association of serum IgA and C4 with severe atherosclerosis","volume":"74","author":"Muscari","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jim.2005.12.003_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000175995","article-title":"Increased serum IgA levels in subjects with previous myocardial infarction or other major ischemic events","volume":"83","author":"Muscari","year":"1993","journal-title":"Cardiology"},{"key":"10.1016\/j.jim.2005.12.003_bib33","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.19.10.1113","article-title":"Elevated plasma levels of transforming growth factor-beta 1 in NIDDM","volume":"19","author":"Pfeiffer","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jim.2005.12.003_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1359-6101(97)00018-X","article-title":"TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases","volume":"8","author":"Pratt","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jim.2005.12.003_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0161-5890(01)00006-2","article-title":"Structural and functional properties of membrane and secreted IgD","volume":"37","author":"Preud'homme","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2005.12.003_bib36","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1172\/JCI110941","article-title":"Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS)","volume":"71","author":"Ringqvist","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2005.12.003_bib37","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1016\/S0021-9258(17)42779-7","article-title":"Occurrence of alpha-d-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units","volume":"259","author":"Spiro","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2005.12.003_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00019501-199703000-00004","article-title":"Altered plasma levels of cytokines in patients with ischemic heart disease","volume":"8","author":"Tashiro","year":"1997","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.jim.2005.12.003_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00019501-200205000-00001","article-title":"Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease","volume":"13","author":"Tashiro","year":"2002","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.jim.2005.12.003_bib40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1084\/jem.166.2.419","article-title":"Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes","volume":"166","author":"Towbin","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2005.12.003_bib41","first-page":"656","article-title":"Serum IgD concentrations in normal individuals 20\u201339 years of age","volume":"42","author":"Tozawa","year":"1994","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.jim.2005.12.003_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0008-6363(97)00033-3","article-title":"Circulating transforming growth factor beta 1 and coronary artery disease","volume":"34","author":"Wang","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jim.2005.12.003_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(79)90389-8","article-title":"Immunochemical studies of the combining sites of the two isolectins, A4 and B4, isolated from Bandeiraea simplicifolia","volume":"198","author":"Wood","year":"1979","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jim.2005.12.003_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00008571-200112000-00004","article-title":"Association of polymorphisms of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis","volume":"11","author":"Yamada","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jim.2005.12.003_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0002-9149(99)00653-0","article-title":"Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels","volume":"85","author":"Zhu","year":"2000","journal-title":"Am. J. Cardiol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175905004205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175905004205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:04:19Z","timestamp":1683367459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175905004205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0022175905004205"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2005.12.003","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}